October 11, 2022: PD Neurotechnology® participated in the PDNSA, in Coventry on October 11th & 12th, 2022. The main theme of the conference was “EVEolution – A Woman’s Journey With Parkinson’s”. The PDNSA allows professionals to share knowledge, expertise and best practices in order to promote the role of the Parkinson’s Nurse Specialist and provides developmental opportunities, education and support.
During the PDNSA conference, Mr Antonis Papadimitriou, Sales and Marketing Executive of PD Neurotechnology®, presented their experience based on the first 7000 days of recording with PDMonitor®, on more than 500 patients in 13 countries worldwide. Finally, he manifested the important role of PD Nurses in the disease management and provided clarifications on the PDMonitor® use by them, especially in the NHS context.
Nikos Moschos, co-Founder and Business Director of PD Neurotechnology® mentioned: “PDMonitor®, our innovative, medical-grade technology which offers continuous monitoring, full symptom coverage and a holistic view of the patient, has reached the important milestone of 7,000 days of recording, until May 2022. Our participation in the PDNSA conference for the 4th consecutive year shows our deep belief in the very important role of the PD nurse in the Parkinson’s patient management. With PDMonitor®, this role may become transformational leading to a plausible paradigm shift.”
You can find the press release here